Back to 
NATIXIS
NATIXIS
MRTXShowing 0 of 9 quarters
Position history for NATIXIS's holdings in MIRATI THERAPEUTICS INC
As of its Q4 2023 13F, Natixis held 215,731 shares of MRTX (Mirati Therapeutics), worth $12.7M. MRTX was 0.1% of Natixis' reported 13F portfolio.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of MRTX: Avoro Capital Advisors LLC